Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 23, Issue 7, Pages 735-744
Publisher
Wiley
Online
2014-04-30
DOI
10.1002/pds.3621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nowotwory po przeszczepie nerki
- (2015) Ewa Watorek et al. Annals of Transplantation
- Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- (2013) Nabeel Khan et al. GASTROENTEROLOGY
- A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
- (2012) Millie D. Long et al. GASTROENTEROLOGY
- Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis
- (2011) Helen French et al. DIGESTIVE DISEASES AND SCIENCES
- Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
- (2011) Harminder Singh et al. GASTROENTEROLOGY
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- Efficacy and safety of adalimumab in Crohn's disease: Meta-analysis of placebo-controlled trials
- (2011) Mei Lan HUANG et al. Journal of Digestive Diseases
- Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease
- (2010) M. A. Smith et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies
- (2010) Natalia Pedersen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study
- (2010) Richard G Armstrong et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of infliximab in Crohnʼs disease
- (2010) H. Hamzaoglu et al. INFLAMMATORY BOWEL DISEASES
- Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study
- (2010) A. C.W. Vos et al. INFLAMMATORY BOWEL DISEASES
- Nonmelanoma skin cancer in inflammatory bowel disease
- (2010) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease
- (2010) Florian Beigel et al. INFLAMMATORY BOWEL DISEASES
- Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis
- (2010) M. S. KRATHEN et al. JOURNAL OF RHEUMATOLOGY
- Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
- (2009) S. SCHNEEWEISS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice
- (2009) Y. ZABANA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab safety in global clinical trials of patients with Crohnʼs disease
- (2009) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
- (2009) Florian Beigel et al. Nature Reviews Gastroenterology & Hepatology
- Cancer risks in Crohn disease patients
- (2008) K. Hemminki et al. ANNALS OF ONCOLOGY
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- (2008) Angelique N. Collamer et al. ARTHRITIS AND RHEUMATISM
- Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality
- (2008) Sarah Caspersen et al. Clinical Gastroenterology and Hepatology
- Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
- (2008) Xavier Treton et al. Clinical Gastroenterology and Hepatology
- Serious Events with Infliximab in Patients with Inflammatory Bowel Disease
- (2008) Hilbert S de Vries et al. DRUG SAFETY
- Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
- (2008) Murat Toruner et al. GASTROENTEROLOGY
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- Risk of nonmelanoma skin cancer with azathioprine use
- (2008) Jessica S. Maddox et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now